MENU
+Compare
STEK
Stock ticker: OTC
AS OF
Jul 25 closing price
Price
$0.03
Change
-$0.00 (-0.00%)
Capitalization
2.98M

STEK Stemtech Corp. Forecast, Technical & Fundamental Analysis

Stemtech Corp is a nutraceutical company... Show more

STEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for STEK with price predictions
Jul 25, 2025

STEK's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for STEK turned positive on July 17, 2025. Looking at past instances where STEK's MACD turned positive, the stock continued to rise in of 57 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 22, 2025. You may want to consider a long position or call options on STEK as a result. In of 113 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where STEK advanced for three days, in of 173 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 47 cases where STEK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

STEK moved below its 50-day moving average on July 18, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for STEK crossed bearishly below the 50-day moving average on July 02, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STEK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for STEK entered a downward trend on July 22, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (63.056). P/E Ratio (1.045) is within average values for comparable stocks, (89.433). STEK's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.124) among similar stocks. P/S Ratio (0.490) is also within normal values, averaging (18.472).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. STEK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STEK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
STEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
10370 USA Today Way
Phone
+1 954 715-6000
Employees
N/A
Web
https://www.stemtech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMPL33.190.32
+0.97%
Simply Good Foods Company (The)
NVR7792.933.54
+0.05%
NVR
CVR12.50-0.01
-0.08%
Chicago Rivet & Machine Co
ISPR2.94-0.05
-1.67%
Ispire Technology
CLB11.73-1.63
-12.20%
Core Laboratories

STEK and Stocks

Correlation & Price change

A.I.dvisor tells us that STEK and CNADF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that STEK and CNADF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STEK
1D Price
Change %
STEK100%
-9.12%
CNADF - STEK
25%
Poorly correlated
N/A
BFRI - STEK
12%
Poorly correlated
+2.31%
HLNCF - STEK
11%
Poorly correlated
-0.51%
PLSH - STEK
8%
Poorly correlated
N/A
EAPIF - STEK
6%
Poorly correlated
N/A
More